GE HealthCare Technologies Inc. $GEHC Stock Position Boosted by Sofinnova Investments Inc.

Sofinnova Investments Inc. boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 160,876 shares of the company’s stock after buying an additional 9,791 shares during the period. Sofinnova Investments Inc.’s holdings in GE HealthCare Technologies were worth $13,195,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the business. Laurel Wealth Advisors LLC purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at about $26,000. Optima Capital LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter worth $27,000. Godfrey Financial Associates Inc. bought a new position in GE HealthCare Technologies in the fourth quarter worth $27,000. Montag A & Associates Inc. lifted its position in GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC lifted its holdings in shares of GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 262 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently issued reports on GEHC. Piper Sandler cut their price target on GE HealthCare Technologies from $88.00 to $74.00 in a report on Thursday, April 30th. BNP Paribas Exane decreased their target price on GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st. Barclays decreased their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a research report on Thursday, April 30th. Wells Fargo & Company cut their price objective on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Finally, Stifel Nicolaus set a $80.00 price objective on GE HealthCare Technologies in a report on Wednesday, April 29th. Nine investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $80.21.

GE HealthCare Technologies Stock Down 0.6%

GEHC stock opened at $64.76 on Tuesday. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $29.46 billion, a PE ratio of 15.49, a PEG ratio of 1.47 and a beta of 0.74. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The business’s 50 day simple moving average is $66.21 and its 200 day simple moving average is $75.07.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm’s revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Insider Transactions at GE HealthCare Technologies

In other news, Director Rodney F. Hochman acquired 1,618 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were purchased at an average cost of $62.03 per share, with a total value of $100,364.54. Following the acquisition, the director directly owned 1,618 shares in the company, valued at $100,364.54. This represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Frank R. Jimenez acquired 1,750 shares of the firm’s stock in a transaction on Thursday, April 30th. The stock was purchased at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the completion of the acquisition, the insider owned 93,932 shares in the company, valued at approximately $5,678,189.40. This represents a 1.90% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last quarter, insiders acquired 21,847 shares of company stock worth $1,361,355. 0.36% of the stock is currently owned by company insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.